Literature DB >> 6309129

The enzymes of pyrimidine biosynthesis in Babesia bovis and Babesia bigemina.

A M Gero, W J O'Sullivan, I G Wright, D F Mahoney.   

Abstract

All six enzymes of de novo pyrimidine biosynthesis leading to the formation of UMP have been demonstrated in whole homogenates from two bovine Babesia species, B. bovis and B. bigemina. The specific activities of the respective enzymes were of the same order of magnitude as observed for the related parasite, Plasmodium berghei. The results indicate that both these parasites have the potential of obtaining their pyrimidine requirements by de novo synthesis. Subcellular fractionation established that dihydroorotate dehydrogenase, the fourth enzyme of the pathway, was of a particulate nature. Mammalian respiratory chain inhibitors and ubiquinone analogues caused inhibition of the Babesia dihydroorotate dehydrogenase. As observed for other eukaryotic systems, the dehydrogenase appears to be linked to a respiratory chain via ubiquinone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309129     DOI: 10.1038/icb.1983.22

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  3 in total

Review 1.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

2.  Purine salvage and metabolism in Babesia bovis.

Authors:  C Matias; S E Nott; A S Bagnara; W J O'Sullivan; A M Gero
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Babesia bovis dihydroorotate dehydrogenase (BboDHODH) is a novel molecular target of drug for bovine babesiosis.

Authors:  Ketsarin Kamyingkird; Shinuo Cao; Tatsunori Masatani; Paul Franck Adjou Moumouni; Patrick Vudriko; Ahmed Abd El Moniem Mousa; Mohamad Alaa Terkawi; Yoshifumi Nishikawa; Ikuo Igarashi; Xuenan Xuan
Journal:  J Vet Med Sci       Date:  2013-11-01       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.